The purpose of this single-arm phase 2 study is to evaluate the efficacy of digoxin in treating relapsed non-SHH, non-WNT medulloblastoma in pediatric and young adult patients.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
David Kram
Pediatrics - Hematology/Oncology
Clinical or Medical
Interventional
Brain, Head, Nervous System
Cancer (Brain and Other Nervous System, Pediatric Cancers)
Child and Teen Health
24-3007
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
